First in Human Study in Healthy Volunteers of Antimicrobial Peptide PL-18 Vaginal Suppositories
Clinical trial NCT05340790 · UNKNOWN
Trial details
- NCT number
- NCT05340790
- Sponsor
- Protelight Pharmaceuticals Australia PTY LTD
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2023-12-04
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.